Sports Medicine Devices – Market Insights – Europe

The European sports medicine market has recovered from the impact of the COVID-19 pandemic to some extent; however, the elective nature of the postponed surgeries is slowing recovery. Favorable demographics, investment in enabling technologies, uptake of premium-priced products, and increased availability and quality of surgeon training will help the market grow at a moderate pace through the forecast period. However, cost controls due to budgetary constraints, regulatory challenges, and the prevalence of alternative treatments will limit ASPs and revenue expansion over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for sports medicine devices in Europe from 2019 through 2031.

The recovery of the European sports medicine market from the impact of the COVID-19 pandemic has been slow.

How were procedure volumes in different segments of the market affected by the crisis?

Which segments have recovered fastest from the impact of COVID-19 and which ones lag behind?

When will each segment of the market return to levels seen prior to the pandemic?

The sports medicine device market is growing due to the adoption of premium-priced technology.

What product innovations are competitors pursuing in order to capitalize on the growing sports medicine device market segments?

How much penetration have current-generation implantable devices gained across the sports medicine device market?

Which segments are most affected by the regulatory environment in Europe?

The leading MNCs have entrenched positions in the European sports medicine device market.

How are the leading competitors leveraging their positions in the market to maintain their market shares?

What strategies can smaller competitors use to gain market share?

Which product segments should competitors focus on for growth opportunities?

Table of contents